Product Information
CYCLOBENZAPRINE 5 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.0215 per EA under NDC 29300041319. Its NADAC has been published 231 times since Mar 23, 2022.
FDA first approved this application on Jul 5, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Unichem Pharmaceuticals (USA) Inc.NDC
29300041319
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213324FDA Approved
7/5/2020
TE Code
AB
On Market Since
7/6/2020
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 5 MG TABLET has been published 231 times since Mar 23, 2022, and over the history we have for it it has declined 27.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0215 per EA |
|---|---|
| All-time high | $0.0294 (Apr 13, 2022) |
| All-time low | $0.0157 (Nov 20, 2024) |
| 52-week high | $0.0219 |
| 52-week low | $0.0209 |
| Median price | $0.0220 |
| Average price | $0.0225 |
| Largest weekly change | +36.3% (Aug 21, 2024) |
| Weeks tracked | 231 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 5 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.0215 per EA (NDC 29300041319), effective Aug 19, 2026.
How has the price of CYCLOBENZAPRINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has declined 27.0%. It has been tracked across 231 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 5 MG TABLET?
Since Mar 23, 2022, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has ranged from a low of $0.0157 (Nov 20, 2024) to a high of $0.0294 (Apr 13, 2022), with a median of $0.0220 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CYCLOBENZAPRINE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE 5 MG TABLET?
CYCLOBENZAPRINE 5 MG TABLET (NDC 29300041319) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.